2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Treatment Considerations, Women’s Health, Biological Processes, Pathogenesis, Genomics, Immune Mechanism, Metabolism, Molecular Biology, Multi-Systemic Interactions, Diseases, Bleeding and Clotting, Platelet Disorders, Thrombocytopenias, Thrombotic Disorders, Immunology, Autoimmune Disorders, Autoimmune Hemolytic Anemia, Infectious Diseases, Viral, Research, Fundamental Science, Translational Research, Study Population, Animal Model
PAPER

3072 Single-cell BCR repertoire profiling identifies clonally expanded B cells with pathogenic anti-PF4/heparin signatures in HIV infection

David W Wang, Mei Yu, PhD2, Demin Wang, PhD3, Renren Wen, PhD4
1 Washington University School of Medicine, St. Louis, Missouri, United States
2 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
3 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
4 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States

Background: Thrombocytopenia is a common hematologic complication of chronic HIV infection, and people living with HIV (PLWH) are at increased risk of arterial and venous thrombosis. Although immune-mediated platelet destruction has long been implicated, the antigen-specific antibody responses linking HIV infection to thrombocytopenia and thrombosis remain poorly defined. Platelet-activating anti-platelet factor 4 (PF4)/heparin antibodies are the underlying cause of heparin-induced thrombocytopenia (HIT), the prototypic platelet-activating antibody-mediated disorder characterized by thrombocytopenia and thrombosis. We previously identified stereotypic B-cell receptor (BCR) signatures of platelet-activating antibodies in HIT, characterized by preferential IGHD3/IGHJ6, IGHD6/IGHJ6, and IGHV3/IGHD3/IGHJ6 rearrangements, unusually long heavy-chain complementarity-determining region 3 (HCDR3) segments, and enrichment of RKH (RX₁-₂R/KX₁-₂R/H) and poly-tyrosine (Y5) HCDR3 motifs (Zhu et al., Blood, 2023). Similar structural features were subsequently identified in prothrombotic antiviral antibodies induced during SARS-CoV-2 infection (Zhu et al., Blood, 2025), suggesting that these signatures may define a broader class of platelet-activating antibody responses in certain infectious diseases rather than being restricted to HIT. Interestingly, a subset of HIV-neutralizing antibodies also possesses unusually long HCDR3s, and our preliminary analyses indicate that some inferred germline clones contain the Y5 motif. We therefore hypothesize that chronic HIV infection promotes expansion of B-cell clones bearing these structural signatures, potentially revealing a previously unrecognized antigen-specific B-cell mechanism underlying HIV-associated thrombocytopenia and thrombosis.

Methods: We analyzed publicly available paired single-cell RNA (scRNA-seq) and V(D)J sequencing data from peripheral blood B cells of 8 PLWH and 24 healthy controls (HC) (Stephenson et al., Nat Med, 2021; Jia et al., iScicence, 2022), yielding 4,661 PLWH and 7,230 HC B and plasma cells after quality control and dataset integration. Cells were clustered into transcriptionally defined subsets and analyzed for immunoglobulin isotype distribution, V(D)J gene usage, clonal expansion, somatic hypermutation, and HCDR3 sequence features.

Results: Unsupervised clustering identified nine transcriptionally distinct B-cell subsets. Compared with HC, PLWH showed significant expansion of plasma cells, DN2/atypical memory B cells (AtyMBCs), transitional B cells, and activated naïve B cells, consistent with an activated and atypical B-cell landscape. Class-switched (IgG/IgA) B cells were enriched across multiple subsets, including activated naïve, transitional, unswitched memory, double negative (DN) 3-, and DN2-/AtyMBCs. BCR repertoire analysis revealed extensive remodeling in PLWH. V-J pairing differed significantly between PLWH and HC at both the cell (PERMANOVA, P<0.01) and clone (P<0.01) levels. Notably, multiple BCR structural features characteristic of platelet-activating antibodies in HIT and COVID-19 were enriched in PLWH. Compared with HCs, B cells from PLWH exhibited significant enrichment of the IGHV3/IGHD3/IGHJ6 (4.10% vs. 1.44%; adjusted P<0.01), IGHD3/IGHJ6 (8.65% vs. 3.08%; adjusted P<0.01), and IGHD6/IGHJ6 (3.46% vs. 0.73%; adjusted P<0.01) rearrangements.  Memory B cells in PLWH also exhibited longer HCDR3s and increased tyrosine content. Consistently, RKH/Y5 motif-positive class-switched B cells and clonotypes were significantly enriched in PLWH, particularly within AtyMBCs, a subset previously associated with platelet-activating antibody responses in COVID-19 (Witman et al., JCI Insight, 2026). Motif-positive clonotypes exhibited significantly greater clonal expansion and larger clone sizes than motif-negative clonotypes, whereas motif-negative clone size did not differ between PLWH and HC. Lineage reconstruction of expanded motif-positive clonotypes demonstrated progressive somatic hypermutation from germline, consistent with antigen-driven affinity maturation.

 

Conclusions: Chronic HIV infection is associated with the expansion and antigen-driven maturation of B-cell clonotypes bearing previously validated platelet-activating BCR features, particularly within the DN2/AtyMBC subset. These findings identify a previously unrecognized antigen-specific B-cell mechanism that may contribute to HIV-associated thrombocytopenia and thrombotic complications.

David W Wang: No relevant conflicts of interest to declare.